-
Mashup Score: 0DOACs Reduce Dementia Risk vs Warfarin in A-Fib - Psychiatry Advisor - 7 month(s) ago
For patients with atrial fibrillation (AF), the use of direct-acting oral anticoagulants (DOACs) significantly reduces dementia risk.
Source: www.psychiatryadvisor.comCategories: Cardiology News and Journals, Latest HeadlinesTweet
Compared with warfarin, DOAC use significantly decreased dementia risk among #AFib patients, according to a systematic review & meta-analysis in #JACCAsia. @PsychiatryAdv reports on the findings here: https://t.co/uF5RLEMU0A #NOAC